Parties d'ouvrages collectifs (1)
Articles dans des revues avec comité de lecture (12)
1.
Chtarto, A., Humbert-Claude, M., Bockstael, O., Das, A. A., Boutry, S., Breger, L. L., Klaver, B., Melas, C., Barroso-Chinea, P., González-Hernández, T., Muller, R. N., De Witte, O., Levivier, M., Lundberg, C., Berkhout, B., & Tenenbaum, L. (2016). A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular therapy. Methods & clinical development, 5, 16027. doi:10.1038/mtm.2016.272.
Bockstael, O., Tenenbaum, L., Dalkara, D., Melas, C., De Witte, O., Levivier, M., & Chtarto, A. (2014). Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional euroinflammation induced by systemic kainic acid treatment. Frontiers in Molecular Neuroscience, 7(DEC), 92. doi:10.3389/fnmol.2014.000923.
Ayuso, E., Leon, X., Bosch, F., Blouin, V., Darmon, C., Moullier, P., Lock, M., Alvira, M. M., McGorray, S., Auricchio, A., Doria, M., Bucher, S., Chtarto, A., Melas, C., Bockstael, O., Clark, R. K., Fountain, W., Gao, G., Gao, K., Giacca, M., Zentilin, L., Kleinschmidt, J., Leuchs, B., Müller, M., Mizukami, H., Ozawa, K., Noordman, Y., Van Der Linden, I., Pythoud, C., Tenenbaum, L., Sumaroka, M., Wright, J. F., Zhang, X., Surosky, R., Weins, B., & Snyder, R. O. (2014). Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Human gene therapy, 25(11), 977-987. doi:10.1089/hum.2014.0574.
Chtarto, A., Bockstael, O., Tshibangu, T., De Witte, O., Levivier, M., & Tenenbaum, L. (2013). A next step in adeno-associated virus-mediated gene therapy for neurological diseases: Regulation and targeting. British journal of clinical pharmacology, 76(2), 217-232. doi:10.1111/bcp.120655.
Chtarto, A., Bockstael, O., Gebara, E., Vermoesen, K., Melas, C., Pythoud, C., Levivier, M., De Witte, O., Luthi-Carter, R., Clinkers, R., & Tenenbaum, L. (2013). An Adeno-Associated Virus-Based Intracellular Sensor of Pathological Nuclear Factor-κB Activation for Disease-Inducible Gene Transfer. PloS one, 8(1), e53156. doi:10.1371/journal.pone.00531566.
Bockstael, O., Melas, C., Pythoud, C., Levivier, M., McCarty, D., Samulski, R. J., De Witte, O., & Tenenbaum, L. (2012). Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors. Human gene therapy, 23(7), 742-753. doi:10.1089/hum.2011.2167.
Yang, X., Mertens, B., Lehtonen, E., Vercammen, L., Bockstael, O., Chtarto, A., Levivier, M., Brotchi, J., Michotte, Y., Baekelandt, V., Sarre, S., & Tenenbaum, L. (2009). Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model. The journal of gene medicine, 11(10), 899-912. doi:10.1002/jgm.13778.
Bockstael, O., Chtarto, A., Wakkinen, J., Yang, X., Melas, C., Levivier, M., Brotchi, J., & Tenenbaum, L. (2008). Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters. Human gene therapy, 19(11), 1293-1305.9.
Lubansu, A., Abeloos, L., Bockstael, O., Lehtonen, E., Blum, D., Brotchi, J., Levivier, M., & Tenenbaum, L. (2008). Recombinant AAV viral vectors serotype 1, 2, and 5 mediate differential gene transfer efficiency in rat striatal fetal grafts. Cell transplantation, 16(10), 1013-1020.10.
Chtarto, A., Yang, X., Bockstael, O., Melas, C., Blum, D., Lehtonen, E., Abeloos, L., Jaspar, J.-M., Levivier, M., Brotchi, J., Velu, T., & Tenenbaum, L. (2007). Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Experimental neurology, 204(1), 387-399. doi:10.1016/j.expneurol.2006.11.01411.
Lauwers, E., Bequé, D., Van Laere, K., Nuyts, J., Bormans, G., Mortelmans, L., Casteels, C., Vercammen, L., Bockstael, O., Nuttin, B., Debyser, Z., & Baekelandt, V. (2007). Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression. Neurobiology of aging, 28(2), 248-257. doi:10.1016/j.neurobiolaging.2005.12.005